糖尿病モニタリング機器の世界市場

糖尿病モニタリング機器の世界市場は2030年までに175億米ドルに達する見込み

2024年に121億米ドルと推定される糖尿病モニタリング機器の世界市場は、2030年には175億米ドルに達し、分析期間2024-2030年のCAGRは6.4%で成長すると予測されます。本レポートで分析したセグメントの1つである自己血糖測定装置は、CAGR 5.2%を記録し、分析期間終了までに110億米ドルに達すると予測されます。持続グルコースモニタリングデバイスセグメントの成長率は、分析期間でCAGR 8.7%と推定されます。

米国市場は33億米ドル、中国はCAGR 9.8％で成長予測

米国の糖尿病モニタリング機器市場は2024年に33億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 9.8%で推移し、2030年には36億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.2%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の糖尿病モニタリング機器市場- 主要動向と促進要因のまとめ

現代の疾病管理において糖尿病モニタリング機器が重要な理由とは？

糖尿病モニタリング機器は、世界で最も蔓延している慢性疾患の1つである糖尿病の管理に欠かせないものとなっており、患者やヘルスケアプロバイダーに血糖値に関するリアルタイムの洞察を提供し、治療計画におけるより良い意思決定を可能にしています。糖尿病は全世界で5億人以上が罹患しており、座りがちな生活習慣、食生活の乱れ、高齢化により急速に増加すると予測されているため、正確でアクセスしやすい継続的なグルコースモニタリングの必要性はかつてないほど高まっています。これらの機器は、血糖コントロールを維持することにより、心血管疾患、神経障害、腎不全、視力低下などの合併症を予防する上で極めて重要な役割を果たしています。血糖測定器（BGM）のような従来の機器は、その手頃な価格と簡便性から依然として広く使用されているが、持続血糖モニタリング（CGM）システムやフラッシュ・グルコース・モニターは、指を刺す必要なしに分単位の最新情報を提供できることから、優位性を獲得しつつあります。Bluetoothとワイヤレス接続の統合により、これらのツールは、アプリと同期し、クラウドデータストレージを可能にし、リアルタイムのアラートを提供するスマートデバイスに変貌し、患者に大きな自律性を与えています。さらに、ヘルスケアシステムは、在宅での慢性疾患管理をますます重視するようになっており、糖尿病モニタリング機器は、個人のケアと、より広範な公衆衛生の成果の両方にとって不可欠なものとなっています。

テクノロジーは糖尿病モニタリング機器の機能にどのような革命をもたらしているのでしょうか？

技術革新は、糖尿病モニタリングの状況を再形成し、デバイスの精度、使いやすさ、そして全体的なデジタルヘルスエコシステムへの統合の向上を促しています。持続グルコースモニター（CGM）は現在、センサー装着期間が最大2週間となり、リアルタイムの追跡と、低血糖または高血糖の差し迫ったイベントを警告する予測アラートが提供されています。バイオセンシング材料と酵素技術の進歩により、皮膚への刺激や校正の必要性を最小限に抑えながら、測定値の精度が向上しています。ウェアラブルデバイスは、より小さく、より目立たず、非侵襲的になりつつあり、赤外線分光法と発汗分析を用いた針を使わないグルコースモニタリングの調査が進行中です。スマートフォンとの統合により、ユーザーはグルコース測定値とともに食事、投薬、運動を記録することができ、AI主導のプラットフォームはこれらの変数を分析して個人に合わせた推奨を提供します。クラウドベースのプラットフォームは、臨床医とのデータ共有を容易にし、遠隔モニタリング、早期介入、来院回数の削減を可能にします。人工膵臓技術とも呼ばれるクローズドループインスリンデリバリーシステムは、インスリンポンプとCGMを組み合わせ、リアルタイムのグルコースデータに基づいてインスリンデリバリーを自動化します。これらの技術革新は、利便性と快適性を向上させるだけでなく、1型糖尿病患者と2型糖尿病患者の転帰を劇的に改善しています。デジタルヘルスとウェアラブルの融合により、糖尿病モニタリングはスマートで予測可能なコネクテッドケアのパラダイムへと進化しつつあります。

なぜ患者のエンパワーメントとライフスタイルの統合がデバイスの普及を促進するのか？

患者中心のケアとライフスタイルに基づいた疾病管理へのシフトが、先進的な糖尿病モニタリング機器の採用を大きく後押ししています。現代の患者は、もはや受動的なケアの受け手ではなく、明確な洞察と実用的なデータを提供しながら、日常生活にシームレスにフィットするツールを期待する能動的な参加者です。スマートウォッチやフィットネストラッカーと通信するCGMのように、日常生活に簡単に統合できるデバイスは、特に技術に精通したユーザーや若い層の間で支持を集めています。リアルタイムのグルコースデータの心理的影響も、食事推奨、運動習慣、投薬スケジュールの遵守を促します。アスリート、多忙な専門家、糖尿病の子供を管理する介護者にとっては、遠隔アラートや動向グラフなどの機能が安心感を与え、状況管理を強化します。これらの機器の多くは現在、多言語インターフェース、音声アシスタント、および病気の仕組みとセルフケアの実践についての理解を促進する教育機能をサポートしています。十分なサービスを受けていない人々においては、アクセスと健康の公平性を改善するために、簡便で手頃な価格のモデルが導入されています。糖尿病に対する認識が高まり、スティグマが減少するにつれ、モニタリング機器は臨床的な道具としてではなく、日常的なウェルネスのパートナーとして見なされるようになってきています。このような認識の変化は、血糖コントロールを成功させ、糖尿病に関連する合併症の全体的な負担を軽減するために重要な要素である、より高い関与と長期的なコミットメントを促進しています。

糖尿病モニタリング機器市場の世界的成長を促進する主な要因は？

糖尿病モニタリング機器市場の成長の原動力は、人口統計学的、技術的、政策的、行動的要因の合流であり、これらの要因の総体として、より良い疾病追跡と個別化されたケアが重視されています。特に、都市化、加工食品の消費、遺伝的素因が新たな診断の急増に拍車をかけている新興国における糖尿病の世界の有病率の上昇が主要な推進力となっています。同時に、先進国では高齢化が進み、慢性疾患管理ツールに対する需要が高まっています。政府のイニシアチブとヘルスケア改革は、グルコースモニタリングデバイスへの補助金、償還範囲の拡大、一般向け啓発キャンペーンの開始によって、支援的な役割を果たしています。パンデミックによって加速した予防医療と遠隔モニタリングの重視の高まりは、ウェアラブル血糖モニターをバーチャルケア戦略の中心に据えました。ハイテク企業とヘルスケアプロバイダーのパートナーシップも、包括的な糖尿病管理のためにウェアラブル、EHR、AIアナリティクスを組み合わせ、より統合的なエコシステムを構築しつつあります。低侵襲でユーザーフレンドリーなデバイスに対する消費者の嗜好が研究開発努力を形成し、メーカーをデザインと機能性の革新へと押し上げています。さらに、業界の主要プレーヤーによるアジア太平洋、ラテンアメリカ、中東への戦略的進出が、新たな成長の道を開いています。技術が成熟し、世界の健康上の優先事項が積極的なケアへとシフトするにつれて、糖尿病モニタリング機器はこの蔓延する疾患を管理するための基盤となるツールになると考えられています。

セグメント

製品タイプ（自己血糖測定器、持続血糖測定器）;適応症（I型糖尿病、II型糖尿病、妊娠糖尿病）;エンドユーザー（病院、診療所、在宅医療現場、その他のエンドユーザー）

調査対象企業の例（注目の合計42社）

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Diabetes Monitoring Devices Market to Reach US$17.5 Billion by 2030

The global market for Diabetes Monitoring Devices estimated at US$12.1 Billion in the year 2024, is expected to reach US$17.5 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Devices, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Continuous Glucose Monitoring Devices segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.8% CAGR

The Diabetes Monitoring Devices market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diabetes Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Diabetes Monitoring Devices Crucial in Modern Disease Management?

Diabetes monitoring devices have become indispensable in the management of one of the world’s most prevalent chronic diseases, offering patients and healthcare providers real-time insights into blood glucose levels and enabling better decision-making in treatment plans. With diabetes affecting over 500 million people globally and projections indicating a rapid rise due to sedentary lifestyles, poor dietary habits, and aging populations, the need for precise, accessible, and continuous glucose monitoring has never been greater. These devices play a pivotal role in preventing complications such as cardiovascular disease, neuropathy, kidney failure, and vision loss by helping maintain glycemic control. Traditional devices like blood glucose meters (BGMs) remain widely used for their affordability and simplicity, but continuous glucose monitoring (CGM) systems and flash glucose monitors are gaining dominance for their ability to provide minute-by-minute updates without the need for finger pricks. The integration of Bluetooth and wireless connectivity has transformed these tools into smart devices that sync with apps, allow for cloud data storage, and offer real-time alerts, empowering patients with greater autonomy. Additionally, healthcare systems are increasingly emphasizing home-based chronic disease management, making diabetes monitoring devices essential to both individual care and broader public health outcomes.

How Is Technology Revolutionizing the Functionality of Diabetes Monitoring Devices?

Technological innovation is reshaping the diabetes monitoring landscape, driving improvements in device accuracy, usability, and integration into holistic digital health ecosystems. Continuous glucose monitors (CGMs) now offer sensor wear times of up to two weeks, with real-time tracking and predictive alerts that warn of impending hypo- or hyperglycemic events. Advances in biosensing materials and enzymatic technology have increased the precision of readings while minimizing skin irritation and calibration needs. Wearable devices are becoming smaller, more discreet, and non-invasive, with research underway for needle-free glucose monitoring using infrared spectroscopy and sweat analysis. Smartphone integration enables users to log meals, medications, and exercise alongside glucose readings, while AI-driven platforms analyze these variables to deliver personalized recommendations. Cloud-based platforms facilitate data sharing with clinicians, allowing for remote monitoring, early intervention, and reduced in-person visits-an advantage magnified during the COVID-19 pandemic. Closed-loop insulin delivery systems, often referred to as artificial pancreas technologies, are combining insulin pumps and CGMs to automate insulin delivery based on real-time glucose data. These innovations are not just enhancing convenience and comfort but are also dramatically improving outcomes for both type 1 and type 2 diabetes patients. As digital health and wearables converge, diabetes monitoring is evolving into a smart, predictive, and connected care paradigm.

Why Is Patient Empowerment and Lifestyle Integration Driving Device Adoption?

The shift toward patient-centered care and lifestyle-based disease management is significantly boosting the adoption of advanced diabetes monitoring devices. Modern patients are no longer passive recipients of care but active participants who expect tools that fit seamlessly into their daily lives while offering clear insights and actionable data. Devices that integrate easily into routine activities-like CGMs that communicate with smartwatches or fitness trackers-are gaining favor, particularly among tech-savvy users and younger demographics. The psychological impact of real-time glucose data also encourages better adherence to dietary recommendations, exercise routines, and medication schedules. For athletes, busy professionals, or caregivers managing children with diabetes, features like remote alerts and trend graphs provide peace of mind and enhanced situational control. Many of these devices now support multilingual interfaces, voice assistants, and educational features that promote understanding of disease mechanics and self-care practices. In underserved populations, simplified and affordable models are being introduced to improve access and health equity. As awareness of diabetes grows and stigma decreases, monitoring devices are increasingly viewed not as clinical tools but as everyday wellness companions. This shift in perception is fostering higher engagement and long-term commitment, critical factors in achieving successful glycemic control and reducing the overall burden of diabetes-related complications.

What Are the Key Drivers Powering Global Growth in the Diabetes Monitoring Devices Market?

The growth in the diabetes monitoring devices market is driven by a confluence of demographic, technological, policy, and behavioral factors that collectively emphasize better disease tracking and personalized care. A major driver is the escalating global prevalence of diabetes, particularly in emerging economies where urbanization, processed food consumption, and genetic predispositions are fueling a surge in new diagnoses. Simultaneously, aging populations in developed nations are contributing to increased demand for chronic disease management tools. Government initiatives and healthcare reforms are playing a supportive role by subsidizing glucose monitoring devices, expanding reimbursement coverage, and launching public awareness campaigns. The growing emphasis on preventive healthcare and remote monitoring-accelerated by the pandemic-has placed wearable glucose monitors at the center of virtual care strategies. Partnerships between tech companies and healthcare providers are also creating more integrated ecosystems, combining wearables, EHRs, and AI analytics for comprehensive diabetes management. Consumer preference for minimally invasive and user-friendly devices is shaping R&D efforts, pushing manufacturers toward innovation in design and functionality. Furthermore, strategic expansion by key industry players into Asia-Pacific, Latin America, and the Middle East is opening new growth avenues. As technology matures and global health priorities shift toward proactive care, diabetes monitoring devices are set to become foundational tools in managing this pervasive disease.

SCOPE OF STUDY:

The report analyzes the Diabetes Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices); Indication (Type-I Diabetes, Type-II Diabetes, Gestational Diabetes); End-User (Hospitals, Clinics, Home Care Settings, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Diabetes Monitoring Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Diabetes Epidemic Throws the Spotlight on Continuous Glucose Monitoring (CGM) Systems
  • Shift Toward Non-Invasive Monitoring Technologies Fuels R&D in Next-Generation Sensor Innovation
  • Growth in Wearable and App-Based Glucose Trackers Accelerates Patient Engagement and Real-Time Monitoring
  • Rising Demand for Personalized Diabetes Management Strengthens Use of Integrated CGM-Insulin Delivery Systems
  • Push Toward Value-Based Care Models Supports Use of Remote Glucose Monitoring in Chronic Disease Programs
  • Expansion of Type 2 Diabetes Screening in Emerging Markets Increases Demand for Affordable Glucometers
  • Adoption of AI and Predictive Analytics in Glucose Data Supports Real-Time Hypo/Hyperglycemia Alerts
  • Growth of Pediatric Diabetes Management Drives Need for Child-Friendly, Low-Burden Monitoring Tools
  • Increased Use of CGM in Gestational Diabetes Management Expands Clinical Application Range
  • Integration with EHR and Telehealth Services Enables Endocrinologist-Patient Collaboration
  • Consumer Preference for Discreet, Pain-Free Devices Propels Innovation in Skin-Adhesive Patch Monitors
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Diabetes Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Self-Monitoring Blood Glucose Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Continuous Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Type-I Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Type-II Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Gestational Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION